ReviveMed
| ISIN | 🆔 |
|---|---|
| Industry | Health technology |
| Founded 📆 | 2017 |
| Founder 👔 | Leila Pirhaji |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | {{URL|example.com|optional display text}} |
| 📇 Address | |
| 📞 telephone | |
ReviveMed is a biotech start-up that analyses metabolomic data using artificial intelligence, which allows them to design new medical therapeutics.
Background[edit]
ReviveMed can distinguish similar mass metabolites and correlate them to drugs, protein effects and the outcomes of disease.[1] The company translates data from metabolites into therapeutic solutions.[2] ReviveMed are working on untreatable diseases which have shown a good chance of treatment.[1] The founder and CEO, Leila Pirhaji,[3] is one of the first to use large-scale metabolomic data to treat these diseases.[4][5] They secured $1.5 million in a seed round in 2018 and $200,000 at a Google machine learning competition.[1] Their technology was published in Nature Methods.[6] ReviveMed won the BioTech Award at the ExtremeTech Challenge 2018.[7]
Leila Pirhaji, ReviveMed founder, is an Iranian scientist and entrepreneur.[3] Pirhaji earned a Bachelor's degree in Biotechnology from the University of Tehran in 2008 and a Master's degree in 2010.[8] She began working on metabolomics during her doctoral studies at the Massachusetts Institute of Technology (MIT).[1] She studied the interactions between proteins and metabolites.[1] During her PhD, she worked as an intern at Merck & Co.[8] She recognised that machine learning could be useful to analyse these interactions. Together with her advisor Ernest Fraenkel, Pirhaji founded ReviveMed.[1] She completed her PhD at MIT in 2016.[9][10]
References[edit]
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 Coldewey, Devin (2018-04-18). "ReviveMed turns drug discovery into a big data problem and raises $1.5M to solve it". TechCrunch.com. Retrieved 2018-07-30.
- ↑ "Leila Pirhaji ReviveMed - PMWC Precision Medicine World Conference". PMWC Precision Medicine World Conference. Retrieved 2018-07-30.
- ↑ 3.0 3.1 Stendahl, Max (2017-01-31). "Iranian MIT grad and biotech CEO fears for future after Trump ban". bizjournals.com. Retrieved 2018-07-30.
- ↑ Murphy, Meg (2016-06-02). "At MIT, a culture of innovation 'never gets old'". MIT News. Retrieved 2018-07-30.
- ↑ Khosravi, Bijan (2018-03-08). "How Persian Women Entrepreneurs Are Changing The Tech Industry". Forbes. Retrieved 2018-07-30.
- ↑ Pirhaji, Leila; Milani, Pamela; Leidl, Mathias; Curran, Timothy; Avila-Pacheco, Julian; Clish, Clary B; White, Forest M; Saghatelian, Alan; Fraenkel, Ernest (2016). "Revealing disease-associated pathways by network integration of untargeted metabolomics". Nature Methods. 13 (9): 770–776. doi:10.1038/nmeth.3940. ISSN 1548-7091. PMC 5209295. PMID 27479327.
- ↑ "ReviveMed is the BioTech Winner of Extreme Tech Challenge 2018. - ReviveMed Technologies". ReviveMed Technologies. 2018-01-12. Retrieved 2018-07-30.
- ↑ 8.0 8.1 "Bloomberg Executive Profile". bloomberg.com. Bloomberg. Retrieved 2018-07-30.
- ↑ Pirhaji, Leila (2016). Revealing disease-associated pathways and components by systematic integration of large-scale biological data. dspace.mit.edu (PhD thesis). MIT. hdl:1721.1/104227. OCLC 958142368.
- ↑ Leila Pirhaji publications indexed by Google Scholar
External links[edit]
- Lua error in Module:Official_website at line 90: attempt to index field 'wikibase' (a nil value).
This article "ReviveMed" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:ReviveMed. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
